Jcr pharmaceuticals and takeda pharmaceuticals announce discontinuation of gene therapy collaboration

Hyogo, japan--(business wire)--jcr announced the discontinuation of a collaboration with takeda to develop gene therapies using aav combined with the jcr j-brain cargo® technology.

TAK Ratings Summary

TAK Quant Ranking